Literature DB >> 12463168

Regulated intramembrane proteolysis: from the endoplasmic reticulum to the nucleus.

Robert B Rawson1.   

Abstract

Regulated intramembrane proteolysis (Rip) is an ancient and widespread process by which cells transmit information from one compartment (the endoplasmic reticulum) to another (the nucleus). Two separate cleavages that are carried out by two separate proteases are required for Rip. The first protease cleaves its protein substrate within an extracytoplasmic domain; the second cleaves it within a membrane-spanning domain, releasing a functionally active fragment of the target protein. In eukaryotes, examples of Rip can be divided into two classes, according to the proteases that are involved and the orientation of the substrates with the membrane. Class 1 Rip involves type 1 transmembrane proteins and requires presenilin for cleavage within a membrane-spanning domain. In Class 2 Rip, the highly hydrophobic metalloprotease, site-2 protease, is required for cleavage within a membrane-spanning domain and substrates are type 2 transmembrane proteins. Both classes of Rip are implicated in diseases that are important in modern societies, such as hyperlipidaemias (via the sterol regulatory element binding protein pathway) and Alzheimer's disease (via processing of the amyloid precursor protein.)

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12463168     DOI: 10.1042/bse0380155

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  13 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

Review 2.  Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Melinda Frye; Michael J Pagliassotti
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

Review 3.  Trafficking and proteolytic processing of APP.

Authors:  Christian Haass; Christoph Kaether; Gopal Thinakaran; Sangram Sisodia
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

Review 4.  Monitoring proteolytic processing events by quantitative mass spectrometry.

Authors:  Mariel Coradin; Kelly R Karch; Benjamin A Garcia
Journal:  Expert Rev Proteomics       Date:  2017-04-17       Impact factor: 3.940

5.  Cleavage of RseA by RseP requires a carboxyl-terminal hydrophobic amino acid following DegS cleavage.

Authors:  Xiaochun Li; Boyuan Wang; Lihui Feng; Hui Kang; Yang Qi; Jiawei Wang; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

6.  Soluble oligomers of the intramembrane serine protease YqgP are catalytically active in the absence of detergents.

Authors:  Xiaojun Lei; Kwangwook Ahn; Lei Zhu; Iban Ubarretxena-Belandia; Yue-Ming Li
Journal:  Biochemistry       Date:  2008-10-21       Impact factor: 3.162

7.  Spatial separation of Golgi and ER during mitosis protects SREBP from unregulated activation.

Authors:  René Bartz; Li-Ping Sun; Blaine Bisel; Jen-Hsuan Wei; Joachim Seemann
Journal:  EMBO J       Date:  2008-03-06       Impact factor: 11.598

Review 8.  Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.

Authors:  Milena Jovanovic; Gali Guterman-Ram; Joan C Marini
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

9.  The NHB1 (N-terminal homology box 1) sequence in transcription factor Nrf1 is required to anchor it to the endoplasmic reticulum and also to enable its asparagine-glycosylation.

Authors:  Yiguo Zhang; John M Lucocq; Masayuki Yamamoto; John D Hayes
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

Review 10.  The role of proteases in regulating Eph/ephrin signaling.

Authors:  Lakmali Atapattu; Martin Lackmann; Peter W Janes
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.